SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme
2 references·5 citing·26 second hop
Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme (2014)Infectivity of blood components from dono…Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Comparative analysis of tripl…Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Residual risk of transfusion …Re-Entry Evaluation of Chinese Blood Donors with Unconfirmed Hepatitis B Screening Results (2022)Re-Entry Evaluation of Chines…Quality and safety measures in transfusion practice: The experience of eight southern/eastern Mediterranean countries (2020)Quality and safety measures i…Anti‐ HB c screening – is it worth the effort? Results of a 10‐year surveillance programme covering more than 30 million donations in Germany (2019)Anti‐ HB c screening – is it …False positive viral marker results in blood donors and their unintended consequences (2018)False positive viral marker r…The current status of nucleic acid amplification technology in transfusion‐transmitted infectious disease testing (2016)The current status of nucleic…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Residual risk and waste in donated blood with pooled nucleic acid testing (2016)Robust Postdonation Blood Screening Under Prevalence Rate Uncertainty (2017)Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations (2017)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Current risk for transfusion transmitted infections (2007)Reducing the risk of transfusion‐transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006 (2007)Informative Dorfman Screening (2011)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country (2019)The donor notification process from the donor's perspective (2004)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)High rate of hepatitis C virus and human immunodeficiency virus false‐positive results in serologic screening in sub‐Saharan Africa: adverse impact on the blood supply (2019)Follow‐up program for blood donors with unconfirmed screening results reveals a high false‐positive rate in Dalian, China (2020)The consequences of temporary deferral on future whole blood donation (2007)Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006 (2008)Vaccination coverage in German adults (2013)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings (2017)Addressing gaps in international blood availability and transfusion safety in low‐ and middle‐income countries: a NHLBI workshop (2018)International collaboration for blood safety: The French—African experience (2021)Notification and follow‐up of blood donors reactive for transfusion‐transmitted infections: A narrative review of the literature from India (2023)
this work references cited by second hop

References

  • 2005Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus107 cited
  • 2013Comparative analysis of triplex nucleic acid test assays in United States blood donors62 cited

Cited by

  • 2018False positive viral marker results in blood donors and their unintended consequences43 cited
  • 2019Anti‐ HB c screening – is it worth the effort? Results of a 10‐year surveillance programme covering more than 30 million donations in Germany15 cited
  • 2020Quality and safety measures in transfusion practice: The experience of eight southern/eastern Mediterranean countries9 cited
  • 2022Re-Entry Evaluation of Chinese Blood Donors with Unconfirmed Hepatitis B Screening Results8 cited
  • 2016The current status of nucleic acid amplification technology in transfusion‐transmitted infectious disease testing8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work